---
schema_version: "secwatch.filing_event.v1"
accession: "0001564590-22-023139"
form_type: "8-K"
ticker: "SANA"
cik: "0001770121"
company_name: "Sana Biotechnology, Inc."
filed_at: "2022-06-14T23:59:59+00:00"
generated_at: "2026-06-25T02:04:15.625065+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.25
confidence: "low"
source: SEC EDGAR
---

# Sana Biotechnology presents updated corporate deck at Goldman Sachs conference

## Summary
- Company discussed updated corporate presentation at Goldman Sachs 43rd Annual Global Healthcare Conference on June 14, 2022.
- No specific financial or pipeline data disclosed in the filing; presentation content not fully reproduced.
- Filing is a routine Reg FD disclosure; no material changes to previously announced information evident.

## SEC filing metadata
- accession: 0001564590-22-023139
- form_type: 8-K
- ticker: SANA
- cik: 0001770121
- company_name: Sana Biotechnology, Inc.
- filed_at: 2022-06-14T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.25
- confidence: low
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1770121/000156459022023139/0001564590-22-023139-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1770121/000156459022023139/sana-8k_20220614.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001564590-22-023139
- JSON: https://secwatch.observer/filing/0001564590-22-023139.json
- Plain text: https://secwatch.observer/filing/0001564590-22-023139.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.